Page 135 - 73_04
P. 135

VOL. 73 (4), 927-945, 2007  DERIVADOS DE 1,4-DI-N-ÓXIDO DE QUINOXALINA...

(38)  DJUDOVIC, P.; MAIER, W.; PIEKARSKI, G.; SCHORNSTEIN, U. Y ZYMALKOWSKI, F. (1976)
(39)  Synthesis of Quinoline-3-Derivatives and Quinoxaline-2-Derivatives and Their
(40)  Actions against Various Malarial Parasites. Pharmazie 31: 845-849.
(41)  RANGISETTY, J. B.; GUPTA, C.; PRASAD, A. L.; SRINIVAS, P.; SRIDHAR, N.; PARIMOO,
(42)  P. Y VEERANJANEYULU, A. (2001) Synthesis of new arylaminoquinoxalines and
(43)  their antimalarial activity in mice. J. Pharm. Pharmacol. 53: 1409-1413.
(44)  ALDANA, I.; ORTEGA, M. A.; JASO, A.; ZARRANZ, B.; OPORTO, P.; GIMENEZ, A.; MON-
      GE, A. Y DEHARO, E. (2003) Anti-malarial activity of some 7-chloro-2-quinoxa-
(45)  linecarbonitrile-1,4-di-N-oxide derivatives. Pharmazie. 58: 68-69.
(46)  ZARRANZ, B.; JASO, A.; ALDANA, I.; MONGE, A.; MAUREL, S.; DEHARO, E.; JULLIAN, V.
      Y SAUVAIN, M. (2005) Synthesis and antimalarial activity of new 3-arylqui-
(47)  noxaline-2-carbonitrile derivatives. Arzneim.-Forsch. 55: 754-761.
      MARIN, A.; LIMA, L. M.; SOLANO, B.; VICENTE, E.; SILANES, S. P.; MAUREL, S.;
      SAUVAIN, M.; ALDANA, I.; MONGE, A. Y DEHARO, E. (2008) Antiplasmodial Struc-
      ture-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-
      di-N-oxide derivatives. Exp. Parasitol. 118: 25-31.
      ZARRANZ, B.; JASO, A.; LIMA, L. M.; ALDANA, I.; MONGE, A.; MAUREL, S. Y SAUVAIN,
      M. (2006) Antiplasmodial activity of 3-trifluoromethyl-2-carbonylquinoxaline
      di-N-oxide derivatives. Braz. J. Pharm. Sci. 42: 357-361.
      GUILLON, J.; GRELLIER, P.; LABAIED, M.; SONNET, P.; LEGER, J. M.; DEPREZ-POULAIN,
      R.; FORFAR-BARES, I.; DALLEMAGNE, P.; LEMAITRE, N.; PEHOURCQ, F.; ROCHETTE, J.;
      SERGHERAERT, C. Y JARRY, C. (2004) Synthesis, antimalarial activity, and mo-
      lecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-
      a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-
      a]thieno[3,2-e]pyrazines. J. Med. Chem. 47: 1997-2009.
      CERECETTO, H.; DI MAIO, R.; GONZALEZ, M.; RISSO, M.; SAENZ, P.; SEOANE, G.;
      DENICOLA, A.; PELUFFO, G.; QUIJANO, C. Y OLEA-AZAR, C. (1999) 1,2,5-oxadiazole
      N-oxide derivatives and related compounds as potential antitrypanosomal
      drugs: Structure-activity relationships. J. Med. Chem. 42: 1941-1950.
      LORIGA, M.; PIRAS, S.; PAGLIETTI, G.; COSTI, M. P. Y VENTURELLI, A. (2003) Qui-
      noxaline chemistry. Part 15. 4-[2-Quinoxalylmethylenimino]-benzoylglutama-
      tes and -benzoates, 4-[2-quinoxalylmethyl-N-methylamino]-benzoylglutama-
      tes as analogues of classical antifolate agents. Synthesis, elucidation of
      structures and in vitro evaluation of antifolate and anticancer activities. Il
      Farmaco. 58: 51-61.
      HUI, X.; DESRIVOT, J.; BORIES, C.; LOISEAU, P. M.; FRANCK, X.; HOCQUEMILLER, R.
      Y FIGADERE, B. (2006) Synthesis and antiprotozoal activity of some new syn-
      thetic substituted quinoxalines. Bioorg. Med. Chem. Lett. 16: 815-820.

                            945
   130   131   132   133   134   135   136   137   138   139   140